Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy
- 1 January 2014
- journal article
- research article
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 18 (1) , 55-59
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Drug Binding Assays do not Reveal Specific Binding of Lacosamide to Collapsin Response Mediator Protein 2 (CRMP‐2)CNS Neuroscience & Therapeutics, 2012
- Absorption, disposition, metabolic fate and elimination of the anti-epileptic drug lacosamide in humans: mass balance following intravenous and oral administrationEuropean Journal of Drug Metabolism and Pharmacokinetics, 2012
- Preliminary efficacy and safety of lacosamide in children with refractory epilepsyEuropean Journal of Paediatric Neurology, 2012
- Novel Medications for EpilepsyDrugs, 2011
- Experience With Lacosamide in a Series of Children With Drug-Resistant Focal EpilepsyPediatric Neurology, 2011
- Efficacy and tolerability of oral lacosamide as adjunctive therapy in pediatric patients with pharmacoresistant focal epilepsyEpilepsy & Behavior, 2011
- Lacosamide as adjunctive therapy for partial‐onset seizures: A randomized controlled trialEpilepsia, 2010
- New treatment option for partial-onset seizures: efficacy and safety of lacosamideTherapeutic Advances in Neurological Disorders, 2010
- Adjunctive lacosamide for partial‐onset seizures: Efficacy and safety results from a randomized controlled trialEpilepsia, 2009
- Efficacy and Safety of Oral Lacosamide as Adjunctive Therapy in Adults with Partial‐Onset SeizuresEpilepsia, 2007